维诺德·巴拉钱德兰博士在斯隆—凯特林癌症研究所（MSK）的一则新闻稿中表示：“新出炉的一期实验数据十分喜人。数据显示，这款试验治疗性mRNA疫苗有望在接种数年之后激活能够把胰腺癌识别为异物的抗肿瘤T细胞。”该研究由斯隆—凯特林癌症研究所旗下奥拉扬癌症 ...

The trial is jointly conducted at the Fudan University Shanghai Cancer Center and Peking University Cancer Hospital.

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE) and Novavax (NVAX) all gained Friday, a broadly downbeat ...

“While mRNA delivery systems offer a powerful method for achieving transgene-free genome editing, they remain inefficient and challenging in plants,” the team wrote in a paper published in the ...

A team of population geographers looked at around 1,250 Chinese researchers who moved back to mainland China over 12 years ... which both developed their own mRNA Covid vaccines.

Adam Glanzman / Bloomberg via Getty Images Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE ...

saw its share prices grow by 5.34 percent on Friday to finish at $35.53 apiece following news that a new coronavirus with pandemic potential was discovered in China. MRNA traded higher in line ...